a
.
the
aapcc
petition
.
the
aapcc
petition
was
submitted
on
04/30/1991
,
and
was
supplemented
by
an
additional
submission
by
aapcc
on
02/28/1992
.
it
was
based
upon
pediatric
poisoning
data
collected
by
the
aapcc
national
data
collection
system
from
1983
through
1991
.
the
petition
stated
that
iron
products
are
the
leading
cause
of
poisoning
deaths
in
children
under
age
six
.
a
letter
was
submitted
to
the
agency
in
support
of
the
aapcc
petition
by
the
american
academy
of
pediatrics
on
02/17/1993
.
the
aapcc
petition
requested
that
the
agency
take
the
following
actions
concerning
the
labeling
and
formulation
of
ironcontaining
iron
containing
products
:
(
1
)
labeling
.
the
petition
requested
that
fda
declare
labels
on
drug
products
and
food
supplements
containing
30
mg
or
more
of
iron
per
dosage
unit
as
misleading
if
the
label
does
not
clearly
state
that
accidental
pediatric
ingestion
of
these
products
can
be
lethal
.
(
2
)
formulation
.
the
petition
requested
that
the
agency
urge
the
industry
to
voluntarily
reformulate
ironcontaining
iron
containing
products
containing
30
mg
or
more
of
iron
per
dosage
unit
in
less
attractive
dosage
units
,
specifically
avoiding
resemblance
to
popular
candies
.
the
aapcc
petition
also
requested
that
the
agency
initiate
an
educational
effort
to
alert
the
public
and
health
professionals
to
the
dangers
of
accidental
pediatric
ingestion
of
ironcontaining
iron
containing
products
.
the
aapcc
stated
that
efforts
need
to
be
directed
especially
to
parents
,
babysitters
,
daycare
providers
,
and
other
consumers
;
to
pediatricians
,
urging
these
health
professionals
to
target
parents
at
the
6month
month
visit
;
to
obstetricians
,
urging
these
health
professionals
to
educate
mothers
at
the
final
postpartum
visit
;
to
other
health
professionals
who
prescribe
ironcontaining
iron
containing
products
;
and
to
pharmacists
who
dispense
them
.
b
.
the
ag
petition
.
the
ag
petition
,
submitted
on
august
16
,
1993
,
cited
data
on
injuries
and
deaths
attributable
to
accidental
iron
poisoning
in
children
reported
to
the
aapcc
national
data
collection
system
and
reported
to
cpsc
through
1992
.
it
requested
that
the
agency
take
the
following
actions
concerning
the
labeling
,
formulation
,
and
packaging
of
iron
-
containing
products
:
(
1
)
labeling
.
for
ironcontaining
iron
containing
products
containing
30
mg
iron
or
more
per
tablet
or
capsule
,
the
petition
requested
that
the
agency
promulgate
a
regulation
requiring
that
the
label
bear
a
conspicuous
boxed
warning
that
states
:
warning
_
keep
away
from
children
.
contains
iron
which
can
be
harmful
or
fatal
if
swallowed
by
a
child
.
the
petition
recommended
that
this
warning
be
in
bold
face
type
and
in
a
color
that
contrasts
with
the
background
and
with
other
printed
material
on
the
label
and
labeling
.
the
petition
also
recommended
that
immediately
following
the
above
boxed
warning
,
the
following
information
appear
:
acute
overdosage
of
iron
may
cause
nausea
and
vomiting
and
,
in
severe
cases
,
cardiovascular
collapse
and
death
.
for
ironcontaining
iron
containing
products
containing
less
than
30
mg
iron
per
tablet
or
capsule
,
the
petition
recommended
that
the
agency
promulgate
a
regulation
requiring
that
the
label
contain
a
conspicuous
boxed
warning
that
states
:
warning
_
keep
away
from
children
.
contains
iron
which
can
be
harmful
or
fatal
in
large
doses
if
swallowed
by
a
child
.
the
petition
recommended
that
this
warning
also
be
in
boldface
type
and
in
a
color
that
contrasts
with
the
background
and
with
other
printed
material
on
the
label
and
labeling
.
(
2
)
packaging
_
the
petition
recommended
that
fda
require
that
ironcontaining
iron
containing
products
containing
30
mg
or
more
of
iron
per
tablet
or
capsule
be
packaged
in
childresistant
child
resistant
individual
blister
packs
.
(
3
)
formulation
_
the
petition
recommended
that
fda
prohibit
the
manufacture
and
sale
of
adult
formulations
of
ironcontaining
iron
containing
products
that
look
like
candy
or
contain
a
sweet
outer
coating
.
c
.
nonprescription
drug
manufacturers
association
petition
.
the
nonprescription
drug
manufacturers
association
(
ndma
,
a
trade
association
that
represents
us
.
manufacturers
and
distributors
of
nonprescription
medicines
and
vitamin
and
mineral
products
,
submitted
a
citizen
petition
to
fda
on
october
15
,
1993
,
in
response
to
the
ag
petition
.
the
ndma
petition
requested
that
fda
adopt
into
regulation
the
newly
initiated
voluntary
ndma
program
on
the
labeling
,
packaging
,
and
formulation
of
ironcontaining
iron
containing
products
.
ndma
stated
that
it
submitted
a
similar
petition
to
cpsc
requesting
that
cpsc
adopt
into
regulation
the
elements
of
the
voluntary
industry
program
that
are
under
the
regulatory
jurisdiction
of
cpsc
.
the
petition
also
requested
that
fda
deny
the
other
citizen
petitions
submitted
on
ironcontaining
iron
containing
products
and
pediatric
poisoning
insofar
as
they
would
contradict
,
add
to
,
or
subtract
from
the
ndma
program
.
the
ndma
petition
requested
that
fda
adopt
the
following
labeling
,
formulation
,
and
packaging
provisions
:
(
1
)
labeling
.
ironcontaining
iron
containing
products
must
bear
on
the
primary
container
(
or
box
for
blister
packaging
,
glassine
envelope
,
etc
,
conspicuously
,
prominently
,
and
clearly
distinguished
from
other
labeling
by
type
,
color
,
or
contrast
,
the
following
warning
statement
:
warning
:
close
tightly
and
keep
out
of
reach
of
children
.
contains
iron
,
which
can
be
harmful
or
fatal
to
children
in
large
doses
.
in
case
of
accidental
overdose
,
seek
professional
assistance
or
contact
a
poison
control
center
immediately
.
the
petition
stated
that
in
circumstances
in
which
the
packaging
did
not
involve
a
reclosable
crp
element
(
eg
,
cap
to
a
bottle
,
the
term
`
close
tightly
'
would
not
need
to
appear
in
the
warning
statement
.
<
text
>
